very little data, especially regarding the by veil yent omicron booster. we have antibody production data, don t have data on anything related to mortality, long covid, serious infections or hospitalizations and for children we have zero data, they re referencing adult data. with lack of data, how are they making the decisions? laura: the never ending emergency, you called it early on. watch for the emergency to continue long past the emergency. that s when you start asking hard questions why it is in place. dr. hemmati, thanks so much. we gave raymond the night off for his book tour. we have a surprise guest to take us through the wildest stories of the week. stay with us to see who the surprise is. z ray s a1c is down with rybelsus®. i m down with rybelsus®. my a1c is down with rybelsus®.
severe disease as the delta did. that is based on adult data and south africa and united kingdom and our own data in the united states and those studies are on going. but there is a consistent message of lower severity. in terms of transmissibility, it is very high. i had a colleague on service last night at boston children s hospital emergency department and saw multiple children with omicron, well they don t know for sure, but with coronavirus possibly or even likely omicron, although most of the cases are not very severe. the information is still coming in. this is an active and fluid situation. i m going to go on service in infectious disease consultant in the next couple of days at boston children s and i ll be rounding in the hospital so i ll know more. okay, we ll circle back to sa ask you about what you re seeing in the hospital. but in the meantime, i want to ask you about what isolation and quarantine should look like right now. because the governor of new york is suggestin
with covid and you have symptomatic covid, you have about twice the chance of ending up in the icu and 70% greater chance of passing away from this. you know, bad outcomes potentially for the fetus, as well. you know, low preterm labor, low birth weight. one of the reasons i think that, you know, there is that early caution is that pregnant women not as many pregnant women are part of the initial trials, but since then, we ve gotten more trials that included that and now we have adult data, child data and millions of people who have gotten this vaccine including over 5,000 pregnancies that have been recorded in cdc s be safe system. all of them say covid vaccines are safe in pregnancy. they have an immense benefit for the mother, an immense benefit for the children because you re passing on those antibodies to your baby and they re protected, as well. i cannot stress that enough. and because there s so much
right away, people may look at those and say those sound like small numbers, and they are. these are considered bridging trials. so they re basically looking at their previous adult data and they re sort of bridging it to this pediatric data. not only the number of cases but how many antibodies. were the antibodies good in those that were getting the vaccine? and the data looks really strong. as you point out, even after the first dose, there was significant benefit. after the second dose, essentially no cases of covid in the vaccinated group. we ll see how this plays out. but it should be another candidate for people who want to get the vaccine in that age group. and pfizer got s green light earlier this month to start vaccinating folks in the younger age group. how has that rollout been? you know, it s been going really well. it s interesting to me. i want to show you these numbers. it s about 5% of the population. 12 to 15-year-olds. and what we see now is they